can semaglutide cause liver damage A study from the New England Journal of Medicine found new evidence that GLP-1 drugs, like Ozempic and Wegovy, used for diabetes and obesity could also help people with a type of disease. CBS Diabetes and obesity drug shows

Pendulum GLP-1 Probiotic increases GLP-1 naturally *based on preclinical studies Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which induce GLP-1 production

"Im like, Oh, no

Business Impact Goes Beyond Compliance The regulatory consequences extend well beyond the inspection itself

This allows clear identification of which compound causes any effects

Gut, 65(3), 426-435

Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as effective therapies for multiple metabolic disorders, demonstrating significant benefits in weight management and cardiovascular risk reduction in individuals with obesity or type 2 diabetes (T2D) 6,7,8 .The 2025 American Diabetes Association (ADA) Standards of Care have broadened the use of GLP-1R agonists beyond glycemic control, recommending them for patients with T2D and chronic kidney disease, as well as those with T2D, obesity, or prediabetic individuals with nonalcoholic fatty liver disease and heart failure with preserved ejection fraction 9